You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 60 No. 11, November 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Neurological Review
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (228)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Evidence-Based Medicine
 •Neurology, Other
 •Pain
 •Patient-Physician Relationship/ Care
 •Alert me on articles by topic

Advances in Neuropathic Pain

Diagnosis, Mechanisms, and Treatment Recommendations

Robert H. Dworkin, PhD; Miroslav Backonja, MD; Michael C. Rowbotham, MD; Robert R. Allen, MD; Charles R. Argoff, MD; Gary J. Bennett, PhD; M. Catherine Bushnell, PhD; John T. Farrar, MD; Bradley S. Galer, MD; Jennifer A. Haythornthwaite, PhD; David J. Hewitt, MD; John D. Loeser, MD; Mitchell B. Max, MD; Mario Saltarelli, MD, PhD; Kenneth E. Schmader, MD; Christoph Stein, MD; David Thompson, PhD; Dennis C. Turk, PhD; Mark S. Wallace, MD; Linda R. Watkins, PhD; Sharon M. Weinstein, MD

Arch Neurol. 2003;60:1524-1534.

Chronic neuropathic pain, caused by lesions in the peripheral or central nervous system, comes in many forms. We describe current approaches to the diagnosis and assessment of neuropathic pain and discuss the results of recent research on its pathophysiologic mechanisms. Randomized controlled clinical trials of gabapentin, the 5% lidocaine patch, opioid analgesics, tramadol hydrochloride, and tricyclic antidepressants provide an evidence-based approach to the treatment of neuropathic pain, and specific recommendations are presented for use of these medications. Continued progress in basic and clinical research on the pathophysiologic mechanisms of neuropathic pain may make it possible to predict effective treatments for individual patients by application of a pain mechanism–based approach.


From the Department of Anesthesiology, University of Rochester, Rochester, NY (Dr Dworkin); Department of Neurology, University of Wisconsin, Madison (Dr Backonja); Department of Neurology, University of California, San Francisco (Dr Rowbotham); AstraZeneca, Wilmington, Del (Dr Allen); Department of Neurology, North Shore University Hospital, Manhasset, NY (Dr Argoff); Department of Anesthesiology, McGill University, Montreal, Quebec (Drs Bennett and Bushnell); Department of Neurology, University of Pennsylvania, Philadelphia (Dr Farrar); Endo Pharmaceuticals, Chadds Ford, Pa (Dr Galer); Department of Psychiatry, Johns Hopkins University, Baltimore, Md (Dr Haythornthwaite); Ortho-McNeil Pharmaceutical, Raritan, NJ (Dr Hewitt); Departments of Neurosurgery (Dr Loeser) and Anesthesiology (Dr Turk), University of Washington, Seattle; Pain and Neurosensory Mechanisms Branch, National Institute of Dental and Craniofacial Research, Department of Health and Human Services, Bethesda, Md (Dr Max); Pfizer, Groton, Conn (Dr Saltarelli); Department of Medicine and Geriatric Research, Education, and Clinical Center, Duke University and Durham VA Medical Centers, Durham, NC (Dr Schmader); Department of Anesthesiology, Freie Universität Berlin, Berlin, Germany (Dr Stein); Innovus Research Inc, Medford, Mass (Dr Thompson); Department of Anesthesiology, University of California, San Diego (Dr Wallace); Department of Psychology, University of Colorado, Boulder (Dr Watkins); and Department of Anesthesiology, University of Utah, Salt Lake City (Dr Weinstein).


RELATED ARTICLE

Pain 2003
Roger N. Rosenberg
Arch Neurol. 2003;60(11):1520.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Neuropathic pain: Redefinition and a grading system for clinical and research purposes
Treede et al.
Neurology 2008;70:1630-1635.
ABSTRACT | FULL TEXT  

An Integrated Strategy in Two-Dimensional Electrophoresis Analysis Able to Identify Discriminants Between Different Clinical Conditions
Pattini et al.
Exp. Biol. Med. 2008;233:483-491.
ABSTRACT | FULL TEXT  

Experimental autoimmune prostatitis induces chronic pelvic pain
Rudick et al.
Am. J. Physiol. Regul. Integr. Comp. Physiol. 2008;294:R1268-R1275.
ABSTRACT | FULL TEXT  

Clinical trial outcome in neuropathic pain: Relationship to study characteristics
Katz et al.
Neurology 2008;70:263-272.
ABSTRACT | FULL TEXT  

Incidence and Management of Phantom Limb Pain According to World Health Organization Analgesic Ladder in Amputees of Malignant Origin
Mishra et al.
AM J HOSP PALLIAT CARE 2008;24:455-462.
ABSTRACT  

Pregabalin: Its Pharmacology and Use in Pain Management
Gajraj
Anesth. Analg. 2007;105:1805-1815.
ABSTRACT | FULL TEXT  

Review Article: The Rationale for a Multimodal Approach in the Management of Breakthrough Cancer Pain: A Review
Guilherme Soares and Chan
AM J HOSP PALLIAT CARE 2007;24:430-439.
ABSTRACT  

Pain Management in a Patient With Intractable Spinal Cord Injury Pain: A Case Report and Literature Review
Que et al.
Anesth. Analg. 2007;105:1462-1473.
ABSTRACT | FULL TEXT  

Differences and similarities between atypical facial pain and trigeminal neuropathic pain
Forssell et al.
Neurology 2007;69:1451-1459.
ABSTRACT | FULL TEXT  

Medication and treatment use in primary care patients with chronic pain of predominantly neuropathic origin
Torrance et al.
Fam Pract 2007;24:481-485.
ABSTRACT | FULL TEXT  

Complement Induction in Spinal Cord Microglia Results in Anaphylatoxin C5a-Mediated Pain Hypersensitivity
Griffin et al.
J. Neurosci. 2007;27:8699-8708.
ABSTRACT | FULL TEXT  

Do Surgical Patients Benefit from Perioperative Gabapentin/Pregabalin? A Systematic Review of Efficacy and Safety
Tiippana et al.
Anesth. Analg. 2007;104:1545-1556.
ABSTRACT | FULL TEXT  

The impact of neuropathic pain on health-related quality of life: Review and implications
Jensen et al.
Neurology 2007;68:1178-1182.
ABSTRACT | FULL TEXT  

Effects of oral pregabalin and aprepitant on pain and central sensitization in the electrical hyperalgesia model in human volunteers
Chizh et al.
Br J Anaesth 2007;98:246-254.
ABSTRACT | FULL TEXT  

Therapeutic Management of Chronic Neuropathic Pain: An Examination of Pharmacologic Treatment
VADALOUCA et al.
Ann. N. Y. Acad. Sci. 2006;1088:164-186.
ABSTRACT | FULL TEXT  

Acute and subchronic effects of amitriptyline 25mg on actual driving in chronic neuropathic pain patients
Veldhuijzen et al.
J Psychopharmacol 2006;20:782-788.
ABSTRACT  

Neuropathic pain: a practical guide for the clinician.
Gilron et al.
CMAJ 2006;175:265-275.
ABSTRACT | FULL TEXT  

Antidepressant medication use in palliative care
Miller et al.
AM J HOSP PALLIAT CARE 2006;23:127-133.
ABSTRACT  

A cross-sectional survey of health state impairment and treatment patterns in patients with postherpetic neuralgia
van Seventer et al.
Age Ageing 2006;35:132-137.
ABSTRACT | FULL TEXT  

Placebo response in clinical trials of depression and its implications for research on chronic neuropathic pain
Dworkin et al.
Neurology 2005;65:S7-S19.
ABSTRACT | FULL TEXT  

Duloxetine: A balanced and selective norepinephrine- and serotonin-reuptake inhibitor
Westanmo et al.
Am J Health Syst Pharm 2005;62:2481-2490.
ABSTRACT | FULL TEXT  

Pharmacotherapy of neuropathic pain
Allen
Contin Educ Anaesth Crit Care Pain 2005;5:134-137.
FULL TEXT  

Use of Antiepileptic Drugs in the Treatment of Chronic Painful Diabetic Neuropathy
Vinik
J. Clin. Endocrinol. Metab. 2005;90:4936-4945.
ABSTRACT | FULL TEXT  

Practical Management of Patients With Painful Diabetic Neuropathy
Corbett
The Diabetes Educator 2005;31:523-540.
ABSTRACT | FULL TEXT  

Recent advances in postoperative pain therapy
Power
Br J Anaesth 2005;95:43-51.
FULL TEXT  

Contemporary assessment and management of neuropathic pain
Irving
Neurology 2005;64:S21-S27.
ABSTRACT | FULL TEXT  

Transcriptional and Translational Regulation of Glial Activation by Morphine in a Rodent Model of Neuropathic Pain
Tawfik et al.
J. Pharmacol. Exp. Ther. 2005;313:1239-1247.
ABSTRACT | FULL TEXT  

Morphine, Gabapentin, or Their Combination for Neuropathic Pain
Gilron et al.
NEJM 2005;352:1324-1334.
ABSTRACT | FULL TEXT  

Combination Therapy for Neuropathic Pain -- Which Drugs, Which Combination, Which Patients?
Raja and Haythornthwaite
NEJM 2005;352:1373-1375.
FULL TEXT  

Vaginal Apex Resection: A Treatment Option for Vaginal Apex Pain
Lamvu et al.
Obstet Gynecol 2004;104:1340-1346.
ABSTRACT | FULL TEXT  

Gabapentin-induced generalized cutaneous small-vessel leukocytoclastic vasculitis.
Wollina et al.
INT J LOW EXTREM WOUNDS 2004;3:123-124.
 

Adjuvant Analgesics in Cancer Pain Management
Lussier et al.
The Oncologist 2004;9:571-591.
ABSTRACT | FULL TEXT  

Demographics, Pharmacoeconomics, Assessment, and Treatment of Pain in the Elderly
Berdine and Mihalyo
Journal of Pharmacy Practice 2004;17:115-128.
ABSTRACT  

Pain 2003
Rosenberg
Arch Neurol 2003;60:1520-1520.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.